Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

XPhyto: Is Mescaline the Next Big Mood-Modifying Medicine?

It has the potential to be the next frontier in the psychedelics renaissance, and it represents an unprecedented opportunity to innovate a notable advancement in mental health therapy. In anecdotal studies, mescaline has shown promise in treating depression, anxiety, PTSD,...
Marc Davis | April 6, 2021 |

Robust Gold, Silver Projects & Promising Drill Results

(Click to play video.) Affinity Metals Corp. ( TSX-V: AFF , Forum ) is focused on the acquisition, exploration, and development of strategic metal deposits within North America. Affinity is following a hybrid approach of combining the advancement of stra...
Featured Submission | March 29, 2022 |

Coverage Initiated on Biopharma With 'Low Risk/High Margin Assets'

The case is made in a ROTH Capital Partners report for investing in this U.S.-based pharma having multiple shots on goal. In a June 30 research note, analyst Scott Henry reported that ROTH Capital Partners initiated coverage on Fortress Biotech Inc. (FBIO:NASDAQ) ...
Streetwise Reports | July 6, 2019 |

Coverage Initiated on Mining Triple Threat: Explorer, Developer, Producer

The basis of Haywood's investment thesis for this Canadian company is shared in a recent report. In a Nov. 28 research note, analyst Mick Carew reported that Haywood initiated coverage on K92 Mining Inc. (KNT:TSX.V) with a Buy rating and a CA$4.75 per share target p...
Streetwise Reports | December 12, 2019 |

US Biopharma to Launch Phase 3 Trial in Bacterial Vaginosis

Daré Bioscience's study, its prospects and the indication's U.S. market opportunity are discussed in a ROTH Capital Partners report. In a May 15 research note, ROTH Capital Partners analyst Yasmeen Rahimi reviewed why the outlook is positive for Daré Bioscience In...
Streetwise Reports | May 21, 2020 |

Analyst: G1 Minimizes the Carnage of Chemotherapy

ROTH Capital Partners initiates coverage on U.S. oncology biopharma G1 Therapeutics that is now filing an NDA. In a June 26 research note, analyst Tony Butler reported that ROTH Capital Partners initiated coverage on G1 Therapeutics Inc. (GTHX:NASDAQ) with a Buy ...
Streetwise Reports | July 2, 2020 |

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson | July 2, 2024 |

Azarga Gets Thumbs Up from Analysts After Favorable Ruling on NRC License

After receiving a favorable ruling on the NRC license, its focus shifts to project economics. Azarga Uranium Corp. (AZZ:TSX; AZZUF:OTCQB; P8AA:FSE) recently announced that the Atomic Safety and Licensing Board (ASLB) issued its Final Initial Decision, resolving the...
Streetwise Reports | December 27, 2019 |

Firm Upgrades Miner to Outperform Amid Increases in Exploration

Great Panther Mining has earned an Outperform rating from Noble Capital Markets, while three other firms rate it a Buy. Great Panther Mining Ltd. (GPR:TSX; GPL:NYSE.American) has been a beehive of activity this year. On January 6, the company announced th...
Streetwise Reports | March 6, 2020 |

Marvel Discovery kicks off 2021 exploration program at Blackfly gold project in Ontario

Fresh off a company rebrand earlier in 2021 and a recent asset spin-off, Marvel Discovery Corp. ( TSX-V: MARV ) (Frankfurt: O4T1) (IMTFF: OTC PINKS) is now ready to move forward with this year’s exploration plans, beginning with one of the most promis...
Richard (Rick) Mills | May 28, 2021 |
1 2 3 4 5 6 7 8 9 10 ...